Y-mabs announces data to be presented at siop 2021

New york, sept. 16, 2021 (globe newswire) -- y-mabs therapeutics, inc. (“y-mabs”, nasdaq: ymab), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, is pleased to announce the acceptance of two presentations at the international society of pediatric oncology (“siop”) virtual annual congress held october 21 through october 24, 2021.
YMAB Ratings Summary
YMAB Quant Ranking